Article
Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally…
medRxiv · 2025 · Mahadevan, K. K.; Maldonado, A. S.; Li, B.; Bickert, A. A.; Perdyan, A.; Kumbhar, S. V.; Piya, S.; Sockwell, A. M.; Morse, S. J.; Arian, K.; Sugimoto, H.; Shalapour, S.; Hong, D. S.; Heffernan, T. P.; MAITRA, A.; Kalluri, R.
Key facts
| Title | Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancer |
|---|---|
| First author | Mahadevan, K. K.; Maldonado, A. S.; Li, B.; Bickert, A. A.; Perdyan, A.; Kumbhar, S. V.; Piya, S.; Sockwell, A. M.; Morse, S. J.; Arian, K.; Sugimoto, H.; Shalapour, S.; Hong, D. S.; Heffernan, T. P.; MAITRA, A.; Kalluri, R. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.02.28.640711 |
| Devices mentioned | DEN000008, K022086, K802418 |
| Product codes mentioned | JCC, JCI, KIT, MVU, NDS, NJT, PPM, KIS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1